The soluble interleukin-6 receptor and related proteins

被引:40
作者
Rose-John, Stefan [1 ]
机构
[1] Univ Kiel, Dept Biochem, Biochem, D-24098 Kiel, Germany
关键词
ADAM protease; cytokine; receptor; shedding; trans-signaling; inflammation; cancer; CORONARY-HEART-DISEASE; DOUBLE-TRANSGENIC MICE; REGULATORY T-CELLS; IL-6; RECEPTOR; SIGNAL TRANSDUCER; IN-VIVO; INFLAMMATORY ARTHRITIS; RHEUMATOID-ARTHRITIS; CYTOKINE RECEPTORS; LIVER-REGENERATION;
D O I
10.1016/j.beem.2015.07.001
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Interleukin-6 is a cytokine involved in the regulation of the immune system and the central nervous system. Interleukin-6 binds to an interleukin-6 receptor, and then associates with a dimer of the ubiquitously expressed gp130 receptor subunit, which initiates intracellular signaling. The interleukin-6 receptor is found in a soluble form, which is generated by proteolytic cleavage and also to a minor extent by translation from an alternatively spliced mRNA. The complex of interleukin-6 bound to the interleukin-6 receptor can stimulate cells, which only express gp130. Such cells are not responsive to interleukin-6 alone. We have for the first time identified the molecular basis of pro-and anti-inflammatory properties of interleukin-6 and we have defined the generation of the soluble IL-6R as a crucial point in the regulation between these two properties. Furthermore, we have deduced a therapeutic principle, which enables us to exclusively block the pro-inflammatory activities of this important cytokine. (C) 2015 Published by Elsevier Ltd.
引用
收藏
页码:787 / 797
页数:11
相关论文
共 99 条
[1]   Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation:: Evidence in Crohn disease and experimental colitis in vivo [J].
Atreya, R ;
Mudter, J ;
Finotto, S ;
Müllberg, J ;
Jostock, T ;
Wirtz, S ;
Schütz, M ;
Bartsch, B ;
Holtmann, M ;
Becker, C ;
Strand, D ;
Czaja, J ;
Schlaak, JF ;
Lehr, HA ;
Autschbach, F ;
Schürmann, G ;
Nishimoto, N ;
Yoshizaki, K ;
Ito, H ;
Kishimoto, T ;
Galle, PR ;
Rose-John, S ;
Neurath, MF .
NATURE MEDICINE, 2000, 6 (05) :583-588
[2]   Distinct role of gp130 activation in promoting self-renewal divisions by mitogenically stimulated murine hematopoietic stem cells [J].
Audet, J ;
Miller, CL ;
Rose-John, S ;
Piret, JM ;
Eaves, CJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (04) :1757-1762
[3]   Selective blockade of interleukin-6 trans-signaling improves survival in a murine polymicrobial sepsis model [J].
Barkhausen, Tanja ;
Tschernig, Thomas ;
Rosenstiel, Philip ;
van Griensven, Martijn ;
Vonberg, Ralf-Peter ;
Dorsch, Martina ;
Mueller-Heine, Annika ;
Chalaris, Athena ;
Scheller, Juergen ;
Rose-John, Stefan ;
Seegert, Dirk ;
Krettek, Christian ;
Waetzig, Georg H. .
CRITICAL CARE MEDICINE, 2011, 39 (06) :1407-1413
[4]  
BAUMANN H, 1990, MOL BIOL MED, V7, P147
[5]   TGF-β suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling [J].
Becker, C ;
Fantini, MC ;
Schramm, C ;
Lehr, HA ;
Wirtz, S ;
Nikolaev, A ;
Burg, J ;
Strand, S ;
Kiesslich, R ;
Huber, S ;
Ito, H ;
Nishimoto, N ;
Yoshizaki, K ;
Nishimoto, N ;
Galle, PR ;
Blessing, M ;
Rose-John, S ;
Neurath, MF .
IMMUNITY, 2004, 21 (04) :491-501
[6]   Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells [J].
Bettelli, E ;
Carrier, YJ ;
Gao, WD ;
Korn, T ;
Strom, TB ;
Oukka, M ;
Weiner, HL ;
Kuchroo, VK .
NATURE, 2006, 441 (7090) :235-238
[7]   A metalloproteinase disintegrin that releases tumour-necrosis factor-alpha from cells [J].
Black, RA ;
Rauch, CT ;
Kozlosky, CJ ;
Peschon, JJ ;
Slack, JL ;
Wolfson, MF ;
Castner, BJ ;
Stocking, KL ;
Reddy, P ;
Srinivasan, S ;
Nelson, N ;
Boiani, N ;
Schooley, KA ;
Gerhart, M ;
Davis, R ;
Fitzner, JN ;
Johnson, RS ;
Paxton, RJ ;
March, CJ ;
Cerretti, DP .
NATURE, 1997, 385 (6618) :729-733
[8]   IL-6 biology: implications for clinical targeting in rheumatic disease [J].
Calabrese, Leonard H. ;
Rose-John, Stefan .
NATURE REVIEWS RHEUMATOLOGY, 2014, 10 (12) :720-727
[9]   Trans-Signaling Is a Dominant Mechanism for the Pathogenic Actions of Interleukin-6 in the Brain [J].
Campbell, Iain L. ;
Erta, Maria ;
Lim, Sue Ling ;
Frausto, Ricardo ;
May, Ulrike ;
Rose-John, Stefan ;
Scheller, Juergen ;
Hidalgo, Juan .
JOURNAL OF NEUROSCIENCE, 2014, 34 (07) :2503-2513
[10]   NEUROLOGIC DISEASE INDUCED IN TRANSGENIC MICE BY CEREBRAL OVEREXPRESSION OF INTERLEUKIN-6 [J].
CAMPBELL, IL ;
ABRAHAM, CR ;
MASLIAH, E ;
KEMPER, P ;
INGLIS, JD ;
OLDSTONE, MBA ;
MUCKE, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10061-10065